Not available
Quote | Qiagen N.V. (NYSE:QGEN)
Last: | $45.99 |
---|---|
Change Percent: | 0.0% |
Open: | $45.77 |
Close: | $45.99 |
High: | $46.01 |
Low: | $45.45 |
Volume: | 1,078,963 |
Last Trade Date Time: | 05/16/2024 03:00:00 am |
News | Qiagen N.V. (NYSE:QGEN)
Venlo, the Netherlands, May 14, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced an updated version of its clinical decision support platform, QIAGEN Clinical Insight Interpret for NGS molecular profiling of hereditary and somatic diseases, has received ...
2024-05-13 14:06:05 ET More on Qiagen Qiagen N.V. 2024 Q1 - Results - Earnings Call Presentation Qiagen N.V. (QGEN) Q1 2024 Earnings Call Transcript QIAGEN to collaborate with FBI on forensic PCR test Qiagen Non-GAAP EPS of $0.46 beats by $0.02, revenue of $4...
Message Board Posts | Qiagen N.V. (NYSE:QGEN)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $QGEN News Article - QIAGEN N.V. to Release Results for Q3 2022 and Hold Webcast | whytestocks | investorshangout | 10/21/2022 12:30:48 PM |
It's an SBD STOCK. :) 100 HERE WE COME. | retired early | investorshub | 12/22/2021 6:16:48 PM |
Is there anybody OUT THERE? :) | retired early | investorshub | 09/02/2021 12:14:04 AM |
Great company progress. This stock will see the | retired early | investorshub | 05/13/2021 3:24:17 PM |
Added some yesterday. Could be big. :) | retired early | investorshub | 02/02/2021 2:44:45 PM |
News, Short Squeeze, Breakout and More Instantly...
Qiagen N.V. Company Name:
QGEN Stock Symbol:
NYSE Market:
Venlo, the Netherlands, May 14, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced an updated version of its clinical decision support platform, QIAGEN Clinical Insight Interpret for NGS molecular profiling of hereditary and somatic diseases, has received ...
Germantown, Maryland, and Venlo, the Netherlands, May 13, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has cleared the QIAstat-Dx Respiratory Panel Plus syndromic test for clinical use. The QIAstat...
Venlo, the Netherlands, and Washington, D.C., May 07, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a cooperative research and development agreement (CRADA) with the U.S. Federal Bureau of Investigation (FBI) to develop a novel test for its QIAcuity d...